FundedIQ
Biotechnology

MiNDERA Corporation: Funding, Investors & Team (Sep 2026)

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner. It was founded in 2013 and is based in San Francisco, United States.

minderahealth.com LinkedIn South San Francisco, United States 11-50 employees
Biotechnology Health Care Medical Product Research
Total raised
$14.0M
Rounds
1
Latest
Undisclosed round
Jul 2024

MiNDERA Corporation has raised $14.0M across 1 funding round on record, the most recent an undisclosed round of $14.0M announced in Jul 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

MiNDERA Corporation Company Profile and Key Stats

Total funding raised
$14.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$14.0M in Jul 2024
Employees
11-50
reported band
Headquarters
South San Francisco, United States

Latest funding round on record: Jul 2024.

MiNDERA Corporation Funding Rounds

Date
Round
Amount
Undisclosed round
$14.0M

MiNDERA Corporation Founders and Leadership Team

Name
Role
Contact
Tobin Dickerson
Founder
Locked

Contact details for the MiNDERA Corporation team: 1 of 1 has an email address on file.

Start 14-day free trial →

MiNDERA Corporation Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

MiNDERA Corporation's latest round of $14.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like MiNDERA Corporation in Biotechnology and South San Francisco

Companies Similar to MiNDERA Corporation

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

MiNDERA Corporation Funding FAQs

What does MiNDERA Corporation do?

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner. It was founded in 2013 and is based in San Francisco, United States.

How much funding has MiNDERA Corporation raised?

MiNDERA Corporation has raised $14.0M across 1 round on record. The most recent is an undisclosed round of $14.0M announced in Jul 2024.

When did MiNDERA Corporation last raise funding?

MiNDERA Corporation's most recent funding round on record is an undisclosed round of $14.0M, announced in Jul 2024.

Who founded MiNDERA Corporation?

FundedIQ lists Tobin Dickerson (Founder) at MiNDERA Corporation.

Where is MiNDERA Corporation headquartered?

MiNDERA Corporation is based in South San Francisco, California, United States.

How many employees does MiNDERA Corporation have?

MiNDERA Corporation is in the 11-50 employee band.

How does MiNDERA Corporation's funding compare to other Biotechnology startups?

MiNDERA Corporation's latest round of $14.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's MiNDERA Corporation Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MiNDERA Corporation is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.